Abstract: The present invention provides a variety of methods of treatment of acid-sensing ion channel (ASIC) mediated pain, cough, and central nervous system disorders by ASICs inhibition with a series of pyrazinoylguanidine compounds represented by formula (I) as defined herein.
Type:
Application
Filed:
April 3, 2008
Publication date:
November 27, 2008
Applicant:
PARION SCIENCES, Inc.
Inventors:
Michael R. JOHNSON, Richard C. BOUCHER, Andrew J. HIRSH
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Abstract: The present invention relates to compounds represented by formula (I): where the structural variables are as defined herein. The compounds are useful for promoting hydration of mucosal surfaces.
Type:
Grant
Filed:
August 26, 2005
Date of Patent:
August 12, 2008
Assignee:
PARION SCIENCES, Inc.
Inventors:
Michael R. Johnson, Bruce F. Molino, Jianzhong Zhang, Bruce Sargent
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Type:
Application
Filed:
March 17, 2008
Publication date:
July 24, 2008
Applicant:
PARION SCIENCES, Inc.
Inventors:
Michael R. JOHNSON, Bruce F. Molino, Jianzhong Zhang, Bruce Sargent
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Type:
Application
Filed:
March 17, 2008
Publication date:
July 17, 2008
Applicant:
PARION SCIENCES, Inc.
Inventors:
Michael R. JOHNSON, Bruce Molino, Jianzhong Zhang, Bruce Sargent
Abstract: The present invention provides a pyrazinoylguanidine compound represented by formula (I): where the structural variables are as defined herein. The compounds are useful for promoting hydration of mucosal surfaces.
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Type:
Application
Filed:
March 17, 2008
Publication date:
July 10, 2008
Applicant:
PARION SCIENCES, Inc.
Inventors:
Michael R. JOHNSON, Bruce F. Molino, Jianzhong Zhang, Bruce Sargent
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Type:
Grant
Filed:
May 27, 2005
Date of Patent:
June 17, 2008
Assignee:
Parion Sciences, Inc.
Inventors:
Michael R. Johnson, Bruce F. Molino, Jianzhong Zhang, Bruce Sargent
Abstract: The present invention provides compound represented by formula (I): where the structural variables are defined herein. The compounds function as sodium channel blockers and may be used to treat a variety of respiratory conditions.
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Type:
Grant
Filed:
August 26, 2005
Date of Patent:
May 6, 2008
Assignee:
Parion Sciences, Inc.
Inventors:
Michael R. Johnson, Bruce F. Molino, Jianzhong Zhang, Bruce Sargent
Abstract: The present invention relates to compounds represented by formula (I): in which at least one of R3 and R4 is a group represented by formula (A): where the structural variables are defined herein. The compounds are useful for blocking sodium channels.
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Type:
Grant
Filed:
August 26, 2005
Date of Patent:
May 6, 2008
Assignee:
Parion Sciences, Inc.
Inventors:
Michael R. Johnson, Bruce F. Molino, Jianzhong Zhang, Bruce Sargent
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Abstract: The present invention relates to methods and compositions for treating diseases ameliorated by increased mucociliary clearance and mucosal hydration by administering an effective amount of a sodium channel blocker as defined herein and an osmolyte to a subject to a subject in need of increased mucociliary clearance and mucosal hydration.
Type:
Application
Filed:
September 7, 2007
Publication date:
April 17, 2008
Applicant:
PARION SCIENCES, Inc.
Inventors:
Michael Johnson, Richard Boucher, Andrew Hirsh
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.